Gene content    
TGFBI ( by HUGO)
Transforming Growth Factor, Beta-Induced, 68kDa
Tumor suppressor gene
Transforming Growth Factor
Beta-Induced
68kDa
CSD2
BIGH3
CSD1
CSD3
LCD1
Beta Ig-H3
RGD-CAP
RGD-Containing Collagen-Associated Protein
CDG2
CDGG1
CSD
EBMD
Transforming Growth Factor
Beta-Induced
68kD
CDB1
kerato-epithelin
Transforming Growth Factor-Beta-Induced Protein Ig-H3
Kerato-epithelin
NCBI: 5q31    Ensembl: 5q31.1
BGH3_HUMANSize: 683 amino acidsMass: 74681 Da

  • Tissue specificity: Highly expressed in the corneal epithelium [IMAGE] Pathway & Disease-focused RT2 Profiler PCR Arrays including TGFBI: Extracellular Matrix & Adhesion Molecules in human mouse rat TGFB/BMP Signaling Pathway in human mouse rat Primer Products: [IMAGE] OriGe
  • Function:
    UniProtKB/Swiss-Prot Summary: BGH3_HUMAN, Q15582 Function: Binds to type I, II, and IV collagens. This adhesion protein may play an important role in cell-collagen interactions. In cartilage, may be involved in endochondral bone formation
  • Similarity:
    Contains 1 EMI domain
                          
    Contains 4 FAS1 domains [IMAGE]
  • Protein Domain/Family    
    Source ID Domain Name Type
    InterProIPR000782FAS1_domainBeta-Ig-H3/fasciclinDomain
    IPR011489EMI_domainEMIDomain
    BlocksIPB000782Beta-Ig-H3/Fasciclin domainBeta-Ig-H3/Fasciclin domain
    IPB011489EMIEMI

    Gene Ontology    
    Type Term Evidence Source Pub
    Biological Process angiogenesis IEP GOA 11866539
    cell proliferation TAS GOA 1388724
    negative regulation of cell adhesion TAS GOA 8024701
    Cellular Component extracellular space IDA GOA 19478074
    extracellular vesicular exosome IDA GOA 19199708
    trans-Golgi network IDA GOA 19478074
    Molecular Function collagen binding IPI GOA 19478074
    integrin binding TAS GOA 1388724
    protein binding IPI GOA 19478074

    Disorder & Mutation    
    Source Disease
    SWISS-PROTCorneal dystrophy, lattice type 1 (CDL1) [MIM:122200]: A form of lattice corneal dystrophy, a class of inherited stromal amyloidoses characterized by pathognomonic branching lattice figures in the cornea. CDL1 is characterized by progressive visual impairment, and the presence of delicate, double-contoured, interdigitating, elongated deposits that form a reticular pattern in the corneal stroma. Systemic amyloidosis is absent. Recurrent corneal ulceration sometimes occurs. Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTCorneal dystrophy, Groenouw type 1 (CDGG1) [MIM:121900]: A rare form of stromal corneal dystrophy characterized by multiple small deposits in the superficial central corneal stroma, and progressive visual impairment. Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTCorneal dystrophy, epithelial basement membrane (EBMD) [MIM:121820]: A bilateral anterior corneal dystrophy characterized by grayish epithelial fingerprint lines, geographic map-like lines, and dots (or microcysts) on slit-lamp examination. Pathologic studies show abnormal, redundant basement membrane and intraepithelial lacunae filled with cellular debris. Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTCorneal dystrophy, Thiel-Behnke type (CDTB) [MIM:602082]: A bilateral disorder of the cornea characterized by progressive honeycomb-like, subepithelial corneal opacities with recurrent erosions. Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTCorneal dystrophy, Reis-Bucklers type (CDRB) [MIM:608470]: A bilateral disorder of the cornea characterized by intermittent attacks of ocular irritation, recurrent painful corneal erosions starting in childhood, corneal opacities in a geographic pattern at the level of the Bowman layer, and a progressive decrease of visual acuity. The lesions are primarily in Bowman membrane with secondary involvement of the epithelium and superficial part of the stroma. Bowman membrane is almost completely replaced by pathologic materials including disoriented collagen fibrils. Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTCorneal dystrophy, lattice type 3A (CDL3A) [MIM:608471]: A form of lattice corneal dystrophy, a class of inherited stromal amyloidoses characterized by pathognomonic branching lattice figures in the cornea. CDL3A is characterized by decreased visual acuity, and the presence of thick, ropy branching lattice lines and accumulations of amyloid deposits in the corneal stroma. Systemic amyloidosis is absent. CDL3A clinically resembles to lattice corneal dystrophy type 3, but differs in that its age of onset is 70 to 90 years. It has an autosomal dominant inheritance pattern. Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTCorneal dystrophy, Avellino type (CDA) [MIM:607541]: A corneal disease resulting in reduced visual acuity and characterized by gray, crumb-like granular deposits in the anterior third of the stroma in each corneal button. Fusiform amyloid deposits, histochemically and morphologically identical to those of lattice corneal dystrophy, are found in the deeper stroma. Additional features include recurrent corneal erosions, and glare and decreased night vision. Note=The disease is caused by mutations affecting the gene represented in this entry

    TGFBI cross reference    
    PubMed OMIM Entrez Gene NCKU SNP Nucleotide UniProt Genome Data Viewer HomoloGene